315 related articles for article (PubMed ID: 27422127)
21. A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1.
Xia X; Li X; Li F; Wu X; Zhang M; Zhou H; Huang N; Yang X; Xiao F; Liu D; Yang L; Zhang N
Mol Cancer; 2019 Aug; 18(1):131. PubMed ID: 31470874
[TBL] [Abstract][Full Text] [Related]
22. Akt1 and Akt2 Isoforms Play Distinct Roles in Regulating the Development of Inflammation and Fibrosis Associated with Alcoholic Liver Disease.
Reyes-Gordillo K; Shah R; Arellanes-Robledo J; Cheng Y; Ibrahim J; Tuma PL
Cells; 2019 Oct; 8(11):. PubMed ID: 31671832
[TBL] [Abstract][Full Text] [Related]
23. AKT involvement in cisplatin chemoresistance of human uterine cancer cells.
Gagnon V; Mathieu I; Sexton E; Leblanc K; Asselin E
Gynecol Oncol; 2004 Sep; 94(3):785-95. PubMed ID: 15350374
[TBL] [Abstract][Full Text] [Related]
24. Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding.
Héron-Milhavet L; Franckhauser C; Rana V; Berthenet C; Fisher D; Hemmings BA; Fernandez A; Lamb NJ
Mol Cell Biol; 2006 Nov; 26(22):8267-80. PubMed ID: 16982699
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-610 suppresses the proliferation of human glioblastoma cells by repressing CCND2 and AKT3.
Mo X; Cao Q; Liang H; Liu J; Li H; Liu F
Mol Med Rep; 2016 Mar; 13(3):1961-6. PubMed ID: 26782072
[TBL] [Abstract][Full Text] [Related]
26. Akt3 overexpression in the heart results in progression from adaptive to maladaptive hypertrophy.
Taniyama Y; Ito M; Sato K; Kuester C; Veit K; Tremp G; Liao R; Colucci WS; Ivashchenko Y; Walsh K; Shiojima I
J Mol Cell Cardiol; 2005 Feb; 38(2):375-85. PubMed ID: 15698844
[TBL] [Abstract][Full Text] [Related]
27. Overexpression and activation of Akt2 protein in oral squamous cell carcinoma.
Iamaroon A; Krisanaprakornkit S
Oral Oncol; 2009 Oct; 45(10):e175-9. PubMed ID: 19628421
[TBL] [Abstract][Full Text] [Related]
28. Identification of functional domains in AKT responsible for distinct roles of AKT isoforms in pressure-stimulated cancer cell adhesion.
Wang S; Basson MD
Exp Cell Res; 2008 Jan; 314(2):286-96. PubMed ID: 17825284
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of Akt isoforms by RNA silencing suppresses the growth of human prostate cancer cells in vitro and in vivo.
Sasaki T; Nakashiro K; Tanaka H; Azuma K; Goda H; Hara S; Onodera J; Fujimoto I; Tanji N; Yokoyama M; Hamakawa H
Biochem Biophys Res Commun; 2010 Aug; 399(1):79-83. PubMed ID: 20638364
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of AKT3 (PKBγ) and PI3KCA suppresses cell viability and proliferation and induces the apoptosis of glioblastoma multiforme T98G cells.
Paul-Samojedny M; Suchanek R; Borkowska P; Pudełko A; Owczarek A; Kowalczyk M; Machnik G; Fila-Daniłow A; Kowalski J
Biomed Res Int; 2014; 2014():768181. PubMed ID: 24967401
[TBL] [Abstract][Full Text] [Related]
31. Opposing functions of Akt isoforms in lung tumor initiation and progression.
Linnerth-Petrik NM; Santry LA; Petrik JJ; Wootton SK
PLoS One; 2014; 9(4):e94595. PubMed ID: 24722238
[TBL] [Abstract][Full Text] [Related]
32. Diverse involvement of isoforms and gene aberrations of Akt in human lung carcinomas.
Dobashi Y; Tsubochi H; Matsubara H; Inoue J; Inazawa J; Endo S; Ooi A
Cancer Sci; 2015 Jun; 106(6):772-781. PubMed ID: 25855050
[TBL] [Abstract][Full Text] [Related]
33. Alternative AKT2 splicing produces protein lacking the hydrophobic motif regulatory region.
Plotz G; Lopez-Garcia LA; Brieger A; Zeuzem S; Biondi RM
PLoS One; 2020; 15(11):e0242819. PubMed ID: 33253205
[TBL] [Abstract][Full Text] [Related]
34. Distinct roles of AKT isoforms in regulating β1-integrin activity, migration, and invasion in prostate cancer.
Virtakoivu R; Pellinen T; Rantala JK; Perälä M; Ivaska J
Mol Biol Cell; 2012 Sep; 23(17):3357-69. PubMed ID: 22809628
[TBL] [Abstract][Full Text] [Related]
35. Distinct functions of AKT isoforms in breast cancer: a comprehensive review.
Hinz N; Jücker M
Cell Commun Signal; 2019 Nov; 17(1):154. PubMed ID: 31752925
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Akt overexpression in MiaPaCa-2 cells: prohibitin is an Akt substrate both in vitro and in cells.
Han EK; Mcgonigal T; Butler C; Giranda VL; Luo Y
Anticancer Res; 2008; 28(2A):957-63. PubMed ID: 18507042
[TBL] [Abstract][Full Text] [Related]
37. Akt isoform specific effects in ovarian cancer progression.
Linnerth-Petrik NM; Santry LA; Moorehead R; Jücker M; Wootton SK; Petrik J
Oncotarget; 2016 Nov; 7(46):74820-74833. PubMed ID: 27533079
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma.
Koul D; Shen R; Bergh S; Sheng X; Shishodia S; Lafortune TA; Lu Y; de Groot JF; Mills GB; Yung WK
Mol Cancer Ther; 2006 Mar; 5(3):637-44. PubMed ID: 16546978
[TBL] [Abstract][Full Text] [Related]
39. Flavopiridol induces phosphorylation of AKT in a human glioblastoma cell line, in contrast to siRNA-mediated silencing of Cdk9: Implications for drug design and development.
Caracciolo V; Laurenti G; Romano G; Carnevale V; Cimini AM; Crozier-Fitzgerald C; Gentile Warschauer E; Russo G; Giordano A
Cell Cycle; 2012 Mar; 11(6):1202-16. PubMed ID: 22391209
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
